Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes

por Goodwin, Marshall S., Sinyavskaya, Olga, Burg, Franklin, O’Neal, Veronica, Ceballos-Diaz, Carolina, Cruz, Pedro E., Lewis, Jada, Giasson, Benoit I., Davies, Peter, Golde, Todd E., Levites, Yona
Publicado 2021

Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy

por Levites, Yona, Funk, Cory, Wang, Xue, Chakrabarty, Paramita, McFarland, Karen N., Bramblett, Baxter, O’Neal, Veronica, Liu, Xufei, Ladd, Thomas, Robinson, Max, Allen, Mariet, Carrasquillo, Minerva M., Dickson, Dennis, Cruz, Pedro, Ryu, Danny, Li, Hong-Dong, Price, Nathan D., Ertekin-Taner, NIlüfer, Golde, Todd E.
Publicado 2021